106 related articles for article (PubMed ID: 11205668)
1. Upper retropharyngeal node involvement in differentiated thyroid carcinoma demonstrated by 131I scintigraphy.
Leger AF; Baillet G; Dagousset F; Vincenot MI; Izembart M; Clerc J; Barritault L
Br J Radiol; 2000 Dec; 73(876):1260-4. PubMed ID: 11205668
[TBL] [Abstract][Full Text] [Related]
2. Parapharyngeal lymph node involvement in papillary thyroid carcinoma.
Ortapamuk H; Arican P; Alp A
Clin Nucl Med; 2003 Nov; 28(11):947-8. PubMed ID: 14578722
[TBL] [Abstract][Full Text] [Related]
3. Total-body scintigraphy with thallium-201 and iodine-131 in the follow-up of differentiated thyroid cancer.
Carril JM; Quirce R; Serrano J; Banzo I; Jiménez-Bonilla JF; Tabuenca O; Barquín RG
J Nucl Med; 1997 May; 38(5):686-92. PubMed ID: 9170428
[TBL] [Abstract][Full Text] [Related]
4. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
5. Combination of radioiodine (131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma.
Travagli JP; Cailleux AF; Ricard M; Baudin E; Caillou B; Parmentier C; Schlumberger M
J Clin Endocrinol Metab; 1998 Aug; 83(8):2675-80. PubMed ID: 9709930
[TBL] [Abstract][Full Text] [Related]
6. Retropharyngeal node metastasis from papillary thyroid carcinoma.
Otsuki N; Nishikawa T; Iwae S; Saito M; Mohri M; Nibu K
Head Neck; 2007 May; 29(5):508-11. PubMed ID: 17120310
[TBL] [Abstract][Full Text] [Related]
7. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
8. [Papillary thyroid microcarcinoma presenting as cervical lymph node metastasis. Interest of tetrofosmin scintigraphy and lymph node thyroglobulin measurement].
Ajmi S; Hassine H; Sfar R; Grouz Z; Guezguez M; Adelkefi M; Essabbah H
Rev Laryngol Otol Rhinol (Bord); 2006; 127(3):179-82. PubMed ID: 17007193
[TBL] [Abstract][Full Text] [Related]
9. Metastatic papillary carcinoma of the thyroid in a patient previously treated for Graves' disease.
Yunusa GH; Kotze T; Brink A
Ann Afr Med; 2014; 13(2):91-4. PubMed ID: 24705115
[TBL] [Abstract][Full Text] [Related]
10. Role of thallium-201 total-body scintigraphy in follow-up of thyroid carcinoma.
Hoefnagel CA; Delprat CC; Marcuse HR; de Vijlder JJ
J Nucl Med; 1986 Dec; 27(12):1854-7. PubMed ID: 3097277
[TBL] [Abstract][Full Text] [Related]
11. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.
Feine U; Lietzenmayer R; Hanke JP; Held J; Wöhrle H; Müller-Schauenburg W
J Nucl Med; 1996 Sep; 37(9):1468-72. PubMed ID: 8790195
[TBL] [Abstract][Full Text] [Related]
12. [PET-FDG in thyroid cancer with high thyroglobulin levels and negative 131-I scan. A case report].
Ortega F; Maldonado A; Marañes P; Montz R; Pérez-Castejón MJ; Melgarejo M; Ruiz JA; Carreras JL
Rev Esp Med Nucl; 1999; 18(1):50-4. PubMed ID: 10074219
[TBL] [Abstract][Full Text] [Related]
13. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
Seabold JE; Gurll N; Schurrer ME; Aktay R; Kirchner PT
J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma.
Ng DC; Sundram FX; Sin AE
J Nucl Med; 2000 Apr; 41(4):631-5. PubMed ID: 10768563
[TBL] [Abstract][Full Text] [Related]
16. FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma.
Alnafisi NS; Driedger AA; Coates G; Moote DJ; Raphael SJ
J Nucl Med; 2000 Jun; 41(6):1010-5. PubMed ID: 10855626
[TBL] [Abstract][Full Text] [Related]
17. Thallium-201 uptake with negative iodine-131 scintigraphy and serum thyroglobulin in metastatic oxyphilic papillary thyroid carcinoma.
Harder W; Lind P; Molnar M; Mikosch P; Gomez I; Gallowitsch HJ; Kresnik E; Unterweger O; Dinges HP
J Nucl Med; 1998 Feb; 39(2):236-8. PubMed ID: 9476925
[TBL] [Abstract][Full Text] [Related]
18. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?
Cailleux AF; Baudin E; Travagli JP; Ricard M; Schlumberger M
J Clin Endocrinol Metab; 2000 Jan; 85(1):175-8. PubMed ID: 10634383
[TBL] [Abstract][Full Text] [Related]
19. Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131.
Park HM; Perkins OW; Edmondson JW; Schnute RB; Manatunga A
Thyroid; 1994; 4(1):49-54. PubMed ID: 8054861
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy.
Valli N; Catargi B; Ronci N; Leccia F; Guyot M; Roger P; Ducassou D; Tabarin A
Thyroid; 1999 Jun; 9(6):583-9. PubMed ID: 10411121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
